However, although some studies have concluded that the combination of hydroxychloroquine and azithromycin does not contribute significantly to arrhythmias, there is evidence that COVID-19 patients with high levels of IL-6 are more likely to develop arrhythmias when this treatment is used [103]. The gene discussed is IL6; the disease is cardiac arrhythmia.